|
|
Tanzania
|
TAN 21 HM 0474
|
DOLUTEGRAVIR AND LAMIVUDINE
|
DOLUTEGRAVIR AND LAMIVUDINE 50/300 mg
|
Cipla limited, (Goa Unit VII PD II)
|
Registered/Compliant
|
Details →
|
|
|
Kenya
|
H2022/CTD8196/17724
|
DOLUTEGRAVIR AND LAMIVUDINE 50/300 MG TABLET
|
DOLUTEGRAVIR SODIUM AND LAMIVUDINE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-2236
|
DOLUTEGRAVIR AND LAMIVUDINE TABLETS
|
DOLUTEGRAVIR AND LAMIVUDINE
|
CIPLA LIMITED
|
Registered
|
Details →
|
|
|
Botswana
|
BOT2500004
|
DOLUTEGRAVIR AND LAMIVUDINE TABLETS
|
Lamivudine 300mg
|
-
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2500004A
|
DOLUTEGRAVIR AND LAMIVUDINE TABLETS
|
Lamivudine 300mg
|
Mylan Laboratories Limited,
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 26 HM 0038
|
Dolutegravir and Lamivudine Tablets 50 mg/300 mg
|
Dolutegravir Sodium 50 mg/6 mL,Dolutegravir Sodium 52.622 mg/6 mL,Lamivudine 300 mg/6 mL,Magnesium stearate (LIGA MF- 2-V-VEG) 8.250 mg/6 mL,Mannitol (Pearlitol 25C) 145.378 mg/6 mL,Microcrystalline Cellulose (Comprecel M101 D+) 55.000 mg/6 mL,Microcrystalline cellulose (Ceolus KG 1000) 25.000 mg/6 mL,Opadry White 03F180011 25.500 mg/6 mL,Povidone, (kollidon 30) 20.000 mg/6 mL,Purified Water 229.425 mg/6 mL,Purified Water 229.500 mg/6 mL,Purified Water 86.400 mg/6 mL,Sodium Starch Glycolate Type- A (Primojel) 15.000 mg/6 mL,Sodium Starch Glycolate Type- A (Primojel) 18.000 mg/6 mL,Sodium Starch Glycolate Type- A (Primojel) 6.000 mg/6 mL,Sodium Stearyl Fumarate 6.000 mg/6 mL
|
HETERO LABS LIMITED, UNIT III
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2404169
|
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
|
-
|
HETERO LABS LIMITED (UNIT -V)
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2404169A
|
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
|
-
|
HETERO LABS LIMITED (UNIT -V)
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2404169B
|
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
|
-
|
HETERO LABS LIMITED (UNIT -V)
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-26-97
|
Twinaqt Tablets
|
Dolutegravir and Lamivudine Tablets 50 mg/300 mg
|
Emcure Pharmaceuticals Limited
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
RWANDA-FDA25/HM/0312/0045
|
Abacavir, Dolutegravir and Lamivudine
|
Abacavir, Dolutegravir and Lamivudine tablets
|
Laurus Labs Limited,
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 26 HM 0110
|
Abacavir, Dolutegravir and Lamivudine
|
Abacavir 60 mg/6 mL,Dolutegravir 5 mg/6 mL,Lamivudine 30 mg/6 mL
|
LUPIN LIMITED
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TZ 20 H 0115
|
Abacavir, Dolutegravir and Lamivudine
|
Abacavir Sulphate 600 mg,Dolutegravir Sodium 50 mg,Lamivudine 300 mg
|
APL Healthcare Limited, (Unit– IV)
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
RWANDA-FDA25/HM/0051/0041
|
Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension 60mg/5mg/30mg
|
Abacavir, Dolutegravir and Lamivudine
|
Laurus Labs Limited,
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 26 HM 0110
|
Abacavir, Dolutegravir and Lamivudine Tablets for oral suspension 60 mg/5 mg/30 mg
|
Abacavir 60 mg,Dolutegravir 5 mg,Lamivudine 30 mg
|
LUPIN LIMITED
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-26-434
|
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets 60mg / 5mg / 30mg
|
Abacavir Sulfate 70.276 mg,Dolutegravir Sodium 5.260 mg,lamivudine 30.000 mg
|
Micro Labs Limited
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-26-352
|
Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension 60mg/5mg/30mg
|
Abacavir Sulfate 60 mg,Dolutegravir Sodium 5 mg,Lamivudine 30 mg
|
Lupin Ltd
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-26-67
|
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60mg / 5mg / 30mg) Macleods Pharmaceuticals Ltd
|
Abacavir Sulphate 60 mg,Dolutegravir Sodium 5 mg,Lamivudine 30 mg
|
At, Oxalis Labs
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
RWANDA-FDA24/HM/0129/0026
|
KAVIDEZA DISTAB
|
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets 60 mg / 5 mg/ 30 mg
|
MYLAN LABORATORIES LIMITED
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 23 HM 0055
|
Abacavir, Dolutegravir and Lamivudine
|
Abacavir sulfate equivalent to Abacavir 600 mg,Colloidal Silicon Dioxide (Aerosil-200) 8.00 mg,Dolutegravir Sodium equivalent to Dolutegravir 50 mg,Lamivudine 300 mg,Magnesium stearate (Ligamed MF-2-V) 28.5 mg,Mannitol (Pearlitol 50 C) 132.38 mg,Microcrystalline cellulose (Ceolus UF 711) 194.00 mg,Microcrystalline cellulose PH 101 166.72 mg,Opadry II Red 85F550060 41.75 mg/6 mL,Povidone K -30 (Kollidon 30) 20.00 mg,Purified Water q.s ml,Sodium Starch glycolate (Type A) (Primojel) 65.00 mg
|
Laurus Labs Limited Unit II
|
Registered/Compliant
|
Details →
|